These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20718174)

  • 21. [Results of treatment of Graves-Basedow disease with 131I at low calculated doses].
    Gómez Arnaiz N; Gómez Saez JM; Orti Llavería A; Gavaldá Mestre L; Mairal Pairó L; Soler Ramón J
    Rev Clin Esp; 1998 Feb; 198(2):57-60. PubMed ID: 9558917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Results of fractionated radioiodine therapy in 696 patients with hyperthyroidism and 690 patients with non-toxic goiter].
    Klein B; Klein E; Horster FA
    Nuklearmedizin; 1989 Aug; 28(4):129-36. PubMed ID: 2780331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.
    Nordyke RA; Gilbert FI
    J Nucl Med; 1991 Mar; 32(3):411-6. PubMed ID: 2005449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodine treatment of 524 cats with hyperthyroidism.
    Peterson ME; Becker DV
    J Am Vet Med Assoc; 1995 Dec; 207(11):1422-8. PubMed ID: 7493869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study.
    Ceccarelli C; Bencivelli W; Vitti P; Grasso L; Pinchera A
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):331-5. PubMed ID: 15730415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with (131)I of toxic multinodular goiter. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 2000 Jun; 19(3):182-6. PubMed ID: 11062080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism].
    Mihailović J; Malesević M; Stefanović L; Krkljus D
    Med Pregl; 1995; 48(11-12):412-5. PubMed ID: 8643057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the outcome between the calculated dosimetry and the estimated dosimetry of 131I in the treatment of hyperthyroidism.
    Sun JH; Huang HS; Huang MJ; Huang BY; Lin JD; Hsu BR; Chiou SC; Lo SK
    Changgeng Yi Xue Za Zhi; 1995 Dec; 18(4):322-8. PubMed ID: 8851980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75.
    Coover LR; Silberstein EB; Kuhn PJ; Graves MW
    J Nucl Med; 2000 Nov; 41(11):1868-75. PubMed ID: 11079497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J; Pineda G; Arancibia P; Wohllk N
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reduced radiation sensitivity of hyperthyroid goiter with endocrine ophthalmopathy (author's transl)].
    Mertz DP; Koch B
    MMW Munch Med Wochenschr; 1977 Jul; 119(28):945-8. PubMed ID: 408626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule.
    Zakavi SR; Mousavi Z; Davachi B
    Nucl Med Commun; 2009 Feb; 30(2):169-75. PubMed ID: 19194214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial.
    Bal CS; Kumar A; Chandra P
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6536-40. PubMed ID: 16189259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.
    Schiavo M; Bagnara MC; Pomposelli E; Altrinetti V; Calamia I; Camerieri L; Giusti M; Pesce G; Reitano C; Bagnasco M; Caputo M
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):301-7. PubMed ID: 23486350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed dose (555 MBq; 15 mCi) radioiodine for the treatment of hyperthyroidism: outcome and its predictors.
    Gupta SK; McGrath S; Rogers K; Attia J; Lewis G; Viswanathan S; Saul M; Allen L
    Intern Med J; 2010 Dec; 40(12):854-7. PubMed ID: 21199224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study.
    Kok SW; Smit JW; de Craen AJ; Goslings BM; van Eck-Smit BL; Romijn JA
    Nucl Med Commun; 2000 Nov; 21(11):1071-8. PubMed ID: 11192714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of treatment of hyperthyroidism with 125-iodine].
    Glanzmann C; Horst W
    Nucl Med (Stuttg); 1975 Aug; 14(3):207-18. PubMed ID: 1208203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism.
    Kaminski G; Michalkiewicz D; Makowski K; Podgajny Z; Szalus N; Ruchala M; Szczepanek E; Gielerak G
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):501-7. PubMed ID: 21158893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis.
    de Rooij A; Vandenbroucke JP; Smit JW; Stokkel MP; Dekkers OM
    Eur J Endocrinol; 2009 Nov; 161(5):771-7. PubMed ID: 19671708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.